A Study to Assess the Effectiveness and Safety of Treatment With Vedolizumab in Adult Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real Life

A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Switzerland

NCT04989907 ·Status: COMPLETED

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real-World Practice

NCT04890262 ·Status: COMPLETED

A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland

NCT05384080 ·Status: COMPLETED

An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease

NCT00790933 ·Status: COMPLETED ·Phase: PHASE3

An Open Label Single-arm Phase 4 Study of Vedolizumab in Subjects With Newly Diagnosed Active Ulcerative Colitis

NCT03237260 ·Status: WITHDRAWN ·Phase: PHASE4

A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's Disease

NCT04804540 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.

NCT06180382 ·Status: RECRUITING ·Phase: PHASE4

Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

NCT03138655 ·Status: COMPLETED ·Phase: PHASE2

Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease

NCT02425111 ·Status: COMPLETED ·Phase: PHASE3

Entyvio (Vedolizumab) Long Term Safety Study

NCT02674308 ·Status: COMPLETED

A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease

NCT05837897 ·Status: RECRUITING ·Phase: PHASE3

A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

NCT04738942 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Value of Pharmacokinetic Assays in the Prediction of Induction and Maintenance Therapeutic Response in Crohn's Disease

NCT02768532 ·Status: TERMINATED ·Phase: PHASE4

A Study of Vedolizumab in Adults With Crohn's Disease (CD)

NCT05192863 ·Status: COMPLETED

A Study to Assess Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis (UC) Korean Participants

NCT03535649 ·Status: COMPLETED

Phase III Study of MLN0002 (300 mg) in Treatment of Crohn's Disease

NCT02038920 ·Status: COMPLETED ·Phase: PHASE3

The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness

NCT02423512 ·Status: COMPLETED

Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis

NCT03839680 ·Status: UNKNOWN

Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease

NCT02743806 ·Status: TERMINATED ·Phase: PHASE4

EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis

NCT03679546 ·Status: COMPLETED ·Phase: PHASE4

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

NCT06095128 ·Status: RECRUITING ·Phase: PHASE4

Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease

NCT01224171 ·Status: COMPLETED ·Phase: PHASE3

Expanded Access to Vedolizumab for Children and Teenagers With Ulcerative Colitis or Crohn's Disease in the USA

NCT06856135 ·Status: AVAILABLE

Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease

NCT02913508 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis

NCT03221036 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3